Learn more

UNIV INDUSTRY FOUNDATION YONSEI UNIV

Overview
  • Total Patents
    37
  • GoodIP Patent Rank
    42,296
  • Filing trend
    ⇩ 16.0%
About

UNIV INDUSTRY FOUNDATION YONSEI UNIV has a total of 37 patent applications. It decreased the IP activity by 16.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and macromolecular chemistry and polymers are SUOMEN PUNAINEN RISTI VERIPALVELU, SEELIG RENATE and GUANGDONG HAID ANIMAL HUSBANDRY AND VETERINARY RES INSTITUTE CO LTD.

Patent filings in countries

World map showing UNIV INDUSTRY FOUNDATION YONSEI UNIVs patent filings in countries
# Country Total Patents
#1 United States 17
#2 WIPO (World Intellectual Property Organization) 10
#3 EPO (European Patent Office) 7
#4 China 3

Patent filings per year

Chart showing UNIV INDUSTRY FOUNDATION YONSEI UNIVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kim Hyun-Ouk 6
#2 Haam Seungjoo 6
#3 Sung Hak-Joon 4
#4 Choi Jihye 4
#5 Byeon Jeong Hoon 3
#6 Huh Yong-Min 3
#7 Lee Jung Bok 3
#8 Lee Yun Ki 3
#9 Hwang Jung Ho 3
#10 Kang Byunghoon 3

Latest patents

Publication Filing date Title
WO2020197323A1 Hydrogel structure having microchannel network
WO2020197326A1 Artificial tissue model comprising hydrogel structure having microchannel network formed therein
WO2020145776A1 Composition for targeting medullary thyroid cancer
WO2020071806A1 Vascular anastomotic member comprising shape-memory polymer
WO2019093591A1 Information management system for construction project information management automation, and construction project information management method using chat platform
US2017268067A1 Use of EI24 gene
CN109072253A Anti-tumor compositions comprising GM-CSF gene, Flt3L-TRAIL fusion, the shRNA for inhibiting TGF-β expression and inhibition the HSP shRNA expressed
US2016369335A1 Method for synthesizing gene using high-depth oligonucleotide tiling